Dark
Light
Today: January 22, 2026

Adrian Johnson

Biophta Secures €65M to Fuel Growth and Innovation

TLDR: Biophta, a Paris-based preclinical biotech company, raised €6.5M in seed funding to accelerate trials for treating glaucoma and macular edema. Founded by experienced professionals, the company has developed an innovative technology
June 3, 2024
1 276 277 278 279 280 679
Go toTop